StockMacro
Menu

Artivion

$18.16 -22% in 6 monthsMarket cap $886.0M

AORT on XNYS, Health Care, Artivion, Inc., job postings

Measures activity, not value. Not investment advice.

Shares fell 59% in a year while the company posted a $17.6M net loss over 12 months.

  • BadShort interest 3.6M shares, 2.7 times a year earlier, 7.0% of shares
  • GoodQuarterly revenue rose 9.2% to $123.8M from a year earlier

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Industry
Surgical & medical instruments & apparatus (Health Care)
Employees
1,800
Website
artivion.com
Listed
NYSE, US
Last results
5 Nov 2026
Next results
expected around 11 Feb 2027 (an estimate: a year ago it reported on 12 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $123.8M, net loss $7.9M.
Quarter to 31 Dec 2021: revenue $79.4M, net income -$20.1MQuarter to 31 Dec 2021: revenue $79.4M, net income -$20.1MQuarter to 31 Mar 2022: revenue $77.2M, net income -$3.4MQuarter to 31 Mar 2022: revenue $77.2M, net income -$3.4MQuarter to 30 Jun 2022: revenue $80.3M, net income -$4.3MQuarter to 30 Jun 2022: revenue $80.3M, net income -$4.3MQuarter to 30 Sep 2022: revenue $76.8M, net income -$13.7MQuarter to 30 Sep 2022: revenue $76.8M, net income -$13.7MQuarter to 31 Dec 2022: revenue $79.4M, net income $2.2MQuarter to 31 Dec 2022: revenue $79.4M, net income $2.2MQuarter to 31 Mar 2023: revenue $83.2M, net income -$13.5MQuarter to 31 Mar 2023: revenue $83.2M, net income -$13.5MQuarter to 30 Jun 2023: revenue $89.3M, net income -$3.4MQuarter to 30 Jun 2023: revenue $89.3M, net income -$3.4MQuarter to 30 Sep 2023: revenue $87.9M, net income -$9.8MQuarter to 30 Sep 2023: revenue $87.9M, net income -$9.8MQuarter to 31 Dec 2023: revenue $93.7M, net income -$4.0MQuarter to 31 Dec 2023: revenue $93.7M, net income -$4.0MQuarter to 31 Mar 2024: revenue $97.4M, net income $7.5MQuarter to 31 Mar 2024: revenue $97.4M, net income $7.5MQuarter to 30 Jun 2024: revenue $98.0M, net income -$2.1MQuarter to 30 Jun 2024: revenue $98.0M, net income -$2.1MQuarter to 30 Sep 2024: revenue $95.8M, net income -$2.3MQuarter to 30 Sep 2024: revenue $95.8M, net income -$2.3MQuarter to 31 Dec 2024: revenue $97.3M, net income -$16.5MQuarter to 31 Dec 2024: revenue $97.3M, net income -$16.5MQuarter to 31 Mar 2025: revenue $99.0M, net income -$505KQuarter to 31 Mar 2025: revenue $99.0M, net income -$505KQuarter to 30 Jun 2025: revenue $113.0M, net income $1.3MQuarter to 30 Jun 2025: revenue $113.0M, net income $1.3MQuarter to 30 Sep 2025: revenue $113.4M, net income $6.5MQuarter to 30 Sep 2025: revenue $113.4M, net income $6.5MQuarter to 31 Dec 2025: revenue $116.0M, net income $2.4MQuarter to 31 Dec 2025: revenue $116.0M, net income $2.4MQuarter to 31 Mar 2026: revenue $116.3M, net income $1.4MQuarter to 31 Mar 2026: revenue $116.3M, net income $1.4MQuarter to 30 Jun 2026: revenue $125.8M, net income -$13.5MQuarter to 30 Jun 2026: revenue $125.8M, net income -$13.5MQuarter to 30 Sep 2026: revenue $123.8M, net income -$7.9MQuarter to 30 Sep 2026: revenue $123.8M, net income -$7.9M
31 Dec 2021RevenueNet incomeNet losstallest bar $125.8M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$123.8M-$7.9M
30 Jun 2026$125.8M-$13.5M
31 Mar 2026$116.3M$1.4M
31 Dec 2025$116.0M$2.4M
30 Sep 2025$113.4M$6.5M
30 Jun 2025$113.0M$1.3M
31 Mar 2025$99.0M-$505K
31 Dec 2024$97.3M-$16.5M
30 Sep 2024$95.8M-$2.3M
30 Jun 2024$98.0M-$2.1M
31 Mar 2024$97.4M$7.5M
31 Dec 2023$93.7M-$4.0M
30 Sep 2023$87.9M-$9.8M
30 Jun 2023$89.3M-$3.4M
31 Mar 2023$83.2M-$13.5M
31 Dec 2022$79.4M$2.2M
30 Sep 2022$76.8M-$13.7M
30 Jun 2022$80.3M-$4.3M
31 Mar 2022$77.2M-$3.4M
31 Dec 2021$79.4M-$20.1M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $481.9M $422.6M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +14% +13%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$17.6M -$9.1M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$0.36 -$0.24
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 63.3% 64.5% 60.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 2.3% 6.1% -8.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -3.7% -2.2% -10.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -4.0% -26.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. -$44.4M –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $48.4M $73.4M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $363.8M $214.9M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $315.4M $141.4M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.81 0.31
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $9.15
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 28.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 1.8 2.3
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 2.5 2.5
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 2.0 2.8

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
ArtivionAORT (this company) $886.0Mloss1.8+14%-3.7%
OrthoPediatricsKIDS $828.7Mloss3.1+16%-12.8%
SpyGlass PharmaSGP $1.0Bloss–––
AlphatecATEC $1.0Bloss1.2+15%-10.3%
Integra LifeSciencesIART $1.0B79.20.62+0.8%0.8%
iRadimedIRMD $1.0B43.211.6+11%26.8%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$503K

bought $0, sold $503K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+4.4%

215 13F filers vs 206

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

96%

46.9M shares held by 13F filers (30 Sep 2026) of 48.8M outstanding (30 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

7.0%

3.4M shares sold short (30 Oct 2026) of 48.8M outstanding (30 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

7.2

3.4M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-8.7%

3.7M shares sold short in the report before, 3.4M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

60%

60% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 57%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+9.2%

$123.8M vs $113.4M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+182%

$13.0M vs $4.6M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$443K

the 12 months before: $730K

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

1

1 article in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

1.0×

1 article in the last 7 days; its usual week has 1.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Capital spending $13.0M, 2.8× a year earlier
  • Short interest 3.6M, 2.7× a year earlier

Price $18.16 on 20 Nov 2026, -59% over 12 months (12-month range $18.16 to $47.18)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $12.1M in the last 12 months (the 12 months before: -$20.0M).
Revenue per quarter. Revenue $123.8M in the latest quarter, +9.2% on a year earlier.
Capital spending per quarter. Capital spending $13.0M in the latest quarter, +182% on a year earlier.
Institutional holders (13F filers). 215 13F filers reported holding it in the latest 13F quarter, +4.4% on a year earlier.
Federal obligations. Federal obligations: $504K published in the last 12 months, -4.6% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
10 Nov 2026Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 13.0M vs usual 3.6M (2026-09-30); 2.8x the same period a year earlier
13 Oct 2026Sharp changeShort interest spike: short interest spike, 3.6M vs usual 1.7M (2026-09-30); 2.7x the same period a year earlier
29 Sep 2026Sharp changeShort interest spike: short interest spike, 3.3M vs usual 1.7M (2026-09-15); 3.0x the same period a year earlier
11 Aug 2026Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 10.7M vs usual 3.6M (2026-06-30); 3.3x the same period a year earlier
14 May 2026Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 8.0M vs usual 3.6M (2026-03-31); 2.2x the same period a year earlier
19 Feb 2026Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 27.5M vs usual 3.4M (2025-12-31); 19.3x the same period a year earlier
11 Aug 20258-K and other filingsDirector or officer change
11 Aug 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
6 Dec 20238-K and other filingsDirector or officer change
6 Dec 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
29 Sep 20228-K and other filingsDirector or officer change
29 Sep 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Dec 2021: $224K published
Month from 1 Feb 2022: -$756K published
Month from 1 Aug 2022: -$289K published
Month from 1 Dec 2022: -$44K published
Month from 1 Feb 2023: -$1.4M published
Month from 1 Mar 2023: -$776K published
Month from 1 Jun 2023: -$349K published
Month from 1 Nov 2023: -$36K published
Month from 1 Dec 2023: -$274K published
Month from 1 Jan 2024: -$626K published
Month from 1 Feb 2024: -$2.6M published
Month from 1 Mar 2024: -$874K published
Month from 1 May 2024: -$53K published
Month from 1 Aug 2024: -$627K published
Month from 1 Oct 2024: -$325K published
Month from 1 Dec 2024: -$600K published
Month from 1 Feb 2025: -$1.8M published
Month from 1 Mar 2025: -$3.2M published
Month from 1 May 2025: -$923K published
Month from 1 Jun 2025: -$1.2M published
Month from 1 Aug 2025: -$3.6M published
Month from 1 Nov 2025: -$8.7M published
Month from 1 Dec 2025: -$3.6M published
Month from 1 Feb 2026: -$2.3M published
Month from 1 Mar 2026: -$2.7M published
Month from 1 Jun 2026: -$911K published
Month from 1 Aug 2026: -$2.1M published
Month from 1 Sep 2026: -$503K published
Revenue per quarter
Quarter ended 31 Dec 2021: $79.4M, +17% on a year earlier; public on 23 Feb 2022
Quarter ended 31 Mar 2022: $77.2M, +8.6% on a year earlier; public on 7 May 2022
Quarter ended 30 Jun 2022: $80.3M, +5.5% on a year earlier; public on 6 Aug 2022
Quarter ended 30 Sep 2022: $76.8M, +6.4% on a year earlier; public on 5 Nov 2022
Quarter ended 31 Dec 2022: $79.4M, 0% on a year earlier; public on 24 Feb 2023
Quarter ended 31 Mar 2023: $83.2M, +7.8% on a year earlier; public on 6 May 2023
Quarter ended 30 Jun 2023: $89.3M, +11% on a year earlier; public on 5 Aug 2023
Quarter ended 30 Sep 2023: $87.9M, +14% on a year earlier; public on 4 Nov 2023
Quarter ended 31 Dec 2023: $93.7M, +18% on a year earlier; public on 24 Feb 2024
Quarter ended 31 Mar 2024: $97.4M, +17% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $98.0M, +9.8% on a year earlier; public on 10 Aug 2024
Quarter ended 30 Sep 2024: $95.8M, +9.0% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Dec 2024: $97.3M, +3.9% on a year earlier; public on 1 Mar 2025
Quarter ended 31 Mar 2025: $99.0M, +1.6% on a year earlier; public on 7 May 2025
Quarter ended 30 Jun 2025: $113.0M, +15% on a year earlier; public on 9 Aug 2025
Quarter ended 30 Sep 2025: $113.4M, +18% on a year earlier; public on 8 Nov 2025
Quarter ended 31 Dec 2025: $116.0M, +19% on a year earlier; public on 19 Feb 2026
Quarter ended 31 Mar 2026: $116.3M, +18% on a year earlier; public on 9 May 2026
Quarter ended 30 Jun 2026: $125.8M, +11% on a year earlier; public on 8 Aug 2026
Quarter ended 30 Sep 2026: $123.8M, +9.2% on a year earlier; public on 7 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $2.6M, +19% on a year earlier; public on 23 Feb 2022
Quarter ended 31 Mar 2022: $2.2M, +49% on a year earlier; public on 7 May 2022
Quarter ended 30 Jun 2022: $1.8M, -68% on a year earlier; public on 6 Aug 2022
Quarter ended 30 Sep 2022: $2.9M, -12% on a year earlier; public on 5 Nov 2022
Quarter ended 31 Dec 2022: $2.1M, -19% on a year earlier; public on 24 Feb 2023
Quarter ended 31 Mar 2023: $2.2M, 0% on a year earlier; public on 6 May 2023
Quarter ended 30 Jun 2023: $1.8M, -1.4% on a year earlier; public on 5 Aug 2023
Quarter ended 30 Sep 2023: $1.5M, -49% on a year earlier; public on 4 Nov 2023
Quarter ended 31 Dec 2023: $1.9M, -7.9% on a year earlier; public on 24 Feb 2024
Quarter ended 31 Mar 2024: $3.6M, +61% on a year earlier; public on 8 May 2024
Quarter ended 31 Mar 2025: $3.6M, +0.7% on a year earlier; public on 7 May 2025
Quarter ended 30 Jun 2025: $3.3M; public on 9 Aug 2025
Quarter ended 30 Sep 2025: $4.6M; public on 8 Nov 2025
Quarter ended 31 Mar 2026: $8.0M, +120% on a year earlier; public on 9 May 2026
Quarter ended 30 Jun 2026: $10.7M, +227% on a year earlier; public on 8 Aug 2026
Quarter ended 30 Sep 2026: $13.0M, +182% on a year earlier; public on 7 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 117; public on 14 Feb 2022
31 Mar 2022 report: 126; public on 16 May 2022
30 Jun 2022 report: 126; public on 15 Aug 2022
30 Sep 2022 report: 127; public on 14 Nov 2022
31 Dec 2022 report: 124; public on 14 Feb 2023
31 Mar 2023 report: 127; public on 15 May 2023
30 Jun 2023 report: 114; public on 14 Aug 2023
30 Sep 2023 report: 130; public on 14 Nov 2023
31 Dec 2023 report: 134; public on 14 Feb 2024
31 Mar 2024 report: 146; public on 15 May 2024
30 Jun 2024 report: 160; public on 14 Aug 2024
30 Sep 2024 report: 170; public on 14 Nov 2024
31 Dec 2024 report: 174; public on 14 Feb 2025
31 Mar 2025 report: 179; public on 15 May 2025
30 Jun 2025 report: 183; public on 14 Aug 2025
30 Sep 2025 report: 206; public on 14 Nov 2025
31 Dec 2025 report: 238; public on 17 Feb 2026
31 Mar 2026 report: 232; public on 15 May 2026
30 Jun 2026 report: 206; public on 14 Aug 2026
30 Sep 2026 report: 215; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2021: $12K published
Month from 1 Dec 2021: $57K published
Month from 1 Jan 2022: $67K published
Month from 1 Feb 2022: $51K published
Month from 1 Mar 2022: $35K published
Month from 1 Apr 2022: $56K published
Month from 1 May 2022: $156K published
Month from 1 Jun 2022: $114K published
Month from 1 Jul 2022: $60K published
Month from 1 Aug 2022: $56K published
Month from 1 Sep 2022: $80K published
Month from 1 Oct 2022: $72K published
Month from 1 Nov 2022: $35K published
Month from 1 Dec 2022: $86K published
Month from 1 Jan 2023: $181K published
Month from 1 Feb 2023: $97K published
Month from 1 Mar 2023: $55K published
Month from 1 Apr 2023: $95K published
Month from 1 May 2023: $64K published
Month from 1 Jun 2023: $47K published
Month from 1 Jul 2023: $151K published
Month from 1 Aug 2023: $106K published
Month from 1 Sep 2023: $110K published
Month from 1 Oct 2023: $83K published
Month from 1 Nov 2023: $26K published
Month from 1 Dec 2023: $89K published
Month from 1 Jan 2024: $91K published
Month from 1 Feb 2024: $112K published
Month from 1 Mar 2024: $5K published
Month from 1 Apr 2024: $79K published
Month from 1 May 2024: $63K published
Month from 1 Jun 2024: $77K published
Month from 1 Jul 2024: $132K published
Month from 1 Aug 2024: $15K published
Month from 1 Sep 2024: $57K published
Month from 1 Oct 2024: $140K published
Month from 1 Nov 2024: $64K published
Month from 1 Dec 2024: $87K published
Month from 1 Jan 2025: $23K published
Month from 1 Feb 2025: $65K published
Month from 1 Mar 2025: $31K published
Month from 1 Apr 2025: -$57K published
Month from 1 May 2025: $75K published
Month from 1 Jun 2025: $33K published
Month from 1 Jul 2025: $141K published
Month from 1 Aug 2025: $69K published
Month from 1 Sep 2025: $23K published
Month from 1 Oct 2025: -$25K published
Month from 1 Nov 2025: $63K published
Month from 1 Dec 2025: $115K published
Month from 1 Jan 2026: $51K published
Month from 1 Feb 2026: $5K published
Month from 1 Mar 2026: $4K published
Month from 1 Apr 2026: $70K published
Month from 1 May 2026: $36K published
Month from 1 Jun 2026: $30K published
Month from 1 Jul 2026: $58K published
Month from 1 Aug 2026: -$13K published
Month from 1 Sep 2026: $29K published
Month from 1 Oct 2026: $99K published
Month from 1 Nov 2026: $20K published

What is unusual now

  • Made public in the last 90 days: it spent $13.0M on capital projects in the quarter ended 30 Sep 2026, 2.8× the same quarter last year; it also had 3.6M shares sold short in the 30 Sep 2026 report, 2.7× the same report last year. 3 sharp changes in all. Two or more unrelated kinds of activity agreed on 10 Nov 2026.
  • Quarterly capital spending jump: spent $13.0M on capital projects in the quarter ended 30 Sep 2026, 2.8× the same quarter last year Public on 10 Nov 2026.
  • Short interest spike: had 3.6M shares sold short in the 30 Sep 2026 report, 2.7× the same report last year Public on 10 Oct 2026.
  • Insider net buying (open market): Insiders sold a net $12.1M in the last 12 months (the 12 months before: -$20.0M).

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 2 sales, $503K; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
11 Sep 2026Andrew M GreenSVP, Regulatory and QualitySell11,480$24.97$287KForm 4
4 Sep 2026Andrew M GreenSVP, Regulatory and QualitySell8,003$27.04$216KForm 4
20 Aug 2026James P MackinPresident & CEOSell70,000$28.96$2.0MForm 4
17 Aug 2026Lance A BerryEVP, COO, CFO & TreasurerSell715$28.55$20KForm 4
17 Aug 2026Andrew M GreenSVP, Regulatory and QualitySell616$28.55$18KForm 4
12 Aug 2026Jean F HollowaySVP, General CounselSell977$28.49$28KForm 4
15 Jun 2026Andrew M GreenSVP, Regulatory and QualitySellplanned in advance (10b5-1); after exercising options44,001$20.70$911KForm 4
4 Mar 2026John E DavisChief Commercial OfficerSell4,573$37.78$173KForm 4

215 institutions reported shares at the end of Q3 2026, 96% of the shares outstanding; 40 opened a position, 31 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.7.3M15.1%$167.7M+674K+10%
Nomura Asset Management International Inc.3.2M6.49%$72.3M-18K-0.6%
Morgan Stanley2.6M5.42%$60.4M+87K+3.4%
Perceptive Advisors LLC2.1M4.33%$48.2M+375K+22%
Vanguard Capital Management LLC2.1M4.23%$47.1M+58K+2.9%
Juniper Investment Company, LLC2.0M4.14%$46.1MNo change
State Street Corp2.0M4.09%$45.5M+135K+7.3%
Ophir Asset Management Pty Ltd1.7M3.43%$38.2M-127K-7.1%
Conestoga Capital Advisors, LLC1.4M2.81%$31.3M-254K-16%
GW&K Investment Management, LLC1.3M2.73%+538K+68%

Company events

All 43 company events

In 12 months: 1 major agreement. Results releases and routine reports are left out.

FiledWhat happenedSource
7 May 2026Signed a major agreement8-K
29 Sep 2025Signed a major agreement8-K
15 Sep 2025Signed a major agreementSame filing: took on new debt8-K
11 Aug 2025Director or officer change8-K
1 Jul 2024Signed a major agreement8-K
18 Jan 2024Signed a major agreementSame filing: took on new debt8-K
6 Dec 2023Director or officer change8-K
29 Sep 2022Director or officer change8-K

The 5 newest of 53 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

10 Nov 2026confirmed

Confirmed across sources Filings + Financials and Short interest and volume

Artivion (AORT): had 3.6M shares sold short in the 30 Sep 2026 report, 2.7× the same report last year, while it spent $13.0M on capital projects in the quarter ended 30 Sep 2026, 2.8× the same quarter last year. Two unrelated kinds of activity within 28 days.

  • Short interest and volume: Short interest spike, became public on 10 Oct 2026
  • Financials: Quarterly capital spending jump, became public on 10 Nov 2026
2025-09-30: 1.3M2025-10-15: 1.3M2025-10-31: 1.4M2025-11-14: 1.3M2025-11-28: 1.2M2025-12-15: 1.2M2025-12-31: 1.4M2026-01-15: 1.6M2026-01-30: 1.6M2026-02-13: 1.4M2026-02-27: 1.6M2026-03-13: 1.7M2026-03-31: 1.7M2026-04-15: 1.9M2026-04-30: 1.9M2026-05-15: 1.9M2026-05-29: 1.9M2026-06-15: 1.9M2026-06-30: 2.2M2026-07-15: 2.5M2026-07-31: 2.7M2026-08-14: 2.7M2026-08-31: 2.9M2026-09-15: 3.3M2026-09-30: 3.6M
The 30 Sep 2026 report against the 24 reports before it. this reportearliernormal: 1.7M
See the evidence (2 changes)

Short interest and volume: Short interest spike became public on 10 Oct 2026

Artivion had 3.6M shares sold short in the 30 Sep 2026 report, 2.7× the same report last year.

This period
3.6M (the 30 Sep 2026 report)
Normal report (median of 24 earlier)
1.7M
Typical spread (median absolute deviation)
287K
How far from its usual level
+4.6
Same report last year
1.3M
History used
1,703 days
2025-09-30: 1.3M2025-10-15: 1.3M2025-10-31: 1.4M2025-11-14: 1.3M2025-11-28: 1.2M2025-12-15: 1.2M2025-12-31: 1.4M2026-01-15: 1.6M2026-01-30: 1.6M2026-02-13: 1.4M2026-02-27: 1.6M2026-03-13: 1.7M2026-03-31: 1.7M2026-04-15: 1.9M2026-04-30: 1.9M2026-05-15: 1.9M2026-05-29: 1.9M2026-06-15: 1.9M2026-06-30: 2.2M2026-07-15: 2.5M2026-07-31: 2.7M2026-08-14: 2.7M2026-08-31: 2.9M2026-09-15: 3.3M2026-09-30: 3.6M
the 30 Sep 2026 report24 earlier reportsnormal: 1.7M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Financials: Quarterly capital spending jump became public on 10 Nov 2026

Artivion spent $13.0M on capital projects in the quarter ended 30 Sep 2026, 2.8× the same quarter last year.

This period
$13.0M (the quarter ended 30 Sep 2026)
Normal quarter (median of 7 earlier)
$3.6M
Typical spread (median absolute deviation)
$971K
How far from its usual level
+6.5
Same quarter last year
$4.6M
History used
5,844 days
2023-12-31: $1.9M2024-03-31: $3.6M2025-03-31: $3.6M2025-06-30: $3.3M2025-09-30: $4.6M2026-03-31: $8.0M2026-06-30: $10.7M2026-09-30: $13.0M
the quarter ended 30 Sep 20267 earlier quartersnormal: $3.6M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

Check it at the source: SEC EDGAR quarterly reports.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 10 Nov 2026several at once

    had 3.6M shares sold short in the 30 Sep 2026 report, 2.7× the same report last year, while it spent $13.0M on capital projects in the quarter ended 30 Sep 2026, 2.8× the same quarter last year. Two unrelated kinds of activity within 28 days.

    See the evidence (2 changes)

    Short interest and volume: Short interest spike became public on 10 Oct 2026

    Artivion had 3.6M shares sold short in the 30 Sep 2026 report, 2.7× the same report last year.

    This period
    3.6M (the 30 Sep 2026 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    287K
    How far from its usual level
    +4.6
    Same report last year
    1.3M
    History used
    1,703 days
    2025-09-30: 1.3M2025-10-15: 1.3M2025-10-31: 1.4M2025-11-14: 1.3M2025-11-28: 1.2M2025-12-15: 1.2M2025-12-31: 1.4M2026-01-15: 1.6M2026-01-30: 1.6M2026-02-13: 1.4M2026-02-27: 1.6M2026-03-13: 1.7M2026-03-31: 1.7M2026-04-15: 1.9M2026-04-30: 1.9M2026-05-15: 1.9M2026-05-29: 1.9M2026-06-15: 1.9M2026-06-30: 2.2M2026-07-15: 2.5M2026-07-31: 2.7M2026-08-14: 2.7M2026-08-31: 2.9M2026-09-15: 3.3M2026-09-30: 3.6M
    the 30 Sep 2026 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Financials: Quarterly capital spending jump became public on 10 Nov 2026

    Artivion spent $13.0M on capital projects in the quarter ended 30 Sep 2026, 2.8× the same quarter last year.

    This period
    $13.0M (the quarter ended 30 Sep 2026)
    Normal quarter (median of 7 earlier)
    $3.6M
    Typical spread (median absolute deviation)
    $971K
    How far from its usual level
    +6.5
    Same quarter last year
    $4.6M
    History used
    5,844 days
    2023-12-31: $1.9M2024-03-31: $3.6M2025-03-31: $3.6M2025-06-30: $3.3M2025-09-30: $4.6M2026-03-31: $8.0M2026-06-30: $10.7M2026-09-30: $13.0M
    the quarter ended 30 Sep 20267 earlier quartersnormal: $3.6M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  2. 10 Nov 2026Financials change

    spent $13.0M on capital projects in the quarter ended 30 Sep 2026, 2.8× the same quarter last year.

    Same quarter last year: $4.6M; its normal quarter is $3.6M.

    See the evidence
    This period
    $13.0M (the quarter ended 30 Sep 2026)
    Normal quarter (median of 7 earlier)
    $3.6M
    Typical spread (median absolute deviation)
    $971K
    How far from its usual level
    +6.5
    Same quarter last year
    $4.6M
    History used
    5,844 days
    2023-12-31: $1.9M2024-03-31: $3.6M2025-03-31: $3.6M2025-06-30: $3.3M2025-09-30: $4.6M2026-03-31: $8.0M2026-06-30: $10.7M2026-09-30: $13.0M
    the quarter ended 30 Sep 20267 earlier quartersnormal: $3.6M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  3. 10 Oct 2026Short interest and volume change

    had 3.6M shares sold short in the 30 Sep 2026 report, 2.7× the same report last year.

    Same report last year: 1.3M; its normal report is 1.7M.

    See the evidence
    This period
    3.6M (the 30 Sep 2026 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    287K
    How far from its usual level
    +4.6
    Same report last year
    1.3M
    History used
    1,703 days
    2025-09-30: 1.3M2025-10-15: 1.3M2025-10-31: 1.4M2025-11-14: 1.3M2025-11-28: 1.2M2025-12-15: 1.2M2025-12-31: 1.4M2026-01-15: 1.6M2026-01-30: 1.6M2026-02-13: 1.4M2026-02-27: 1.6M2026-03-13: 1.7M2026-03-31: 1.7M2026-04-15: 1.9M2026-04-30: 1.9M2026-05-15: 1.9M2026-05-29: 1.9M2026-06-15: 1.9M2026-06-30: 2.2M2026-07-15: 2.5M2026-07-31: 2.7M2026-08-14: 2.7M2026-08-31: 2.9M2026-09-15: 3.3M2026-09-30: 3.6M
    the 30 Sep 2026 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 25 Sep 2026Short interest and volume change

    had 3.3M shares sold short in the 15 Sep 2026 report, 3.0× the same report last year.

    Same report last year: 1.1M; its normal report is 1.7M.

    See the evidence
    This period
    3.3M (the 15 Sep 2026 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    290K
    How far from its usual level
    +3.8
    Same report last year
    1.1M
    History used
    1,688 days
    2025-09-15: 1.1M2025-09-30: 1.3M2025-10-15: 1.3M2025-10-31: 1.4M2025-11-14: 1.3M2025-11-28: 1.2M2025-12-15: 1.2M2025-12-31: 1.4M2026-01-15: 1.6M2026-01-30: 1.6M2026-02-13: 1.4M2026-02-27: 1.6M2026-03-13: 1.7M2026-03-31: 1.7M2026-04-15: 1.9M2026-04-30: 1.9M2026-05-15: 1.9M2026-05-29: 1.9M2026-06-15: 1.9M2026-06-30: 2.2M2026-07-15: 2.5M2026-07-31: 2.7M2026-08-14: 2.7M2026-08-31: 2.9M2026-09-15: 3.3M
    the 15 Sep 2026 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 11 Aug 2026Financials change

    spent $10.7M on capital projects in the quarter ended 30 Jun 2026, 3.3× the same quarter last year.

    Same quarter last year: $3.3M; its normal quarter is $3.6M.

    See the evidence
    This period
    $10.7M (the quarter ended 30 Jun 2026)
    Normal quarter (median of 7 earlier)
    $3.6M
    Typical spread (median absolute deviation)
    $998K
    How far from its usual level
    +4.8
    Same quarter last year
    $3.3M
    History used
    5,752 days
    2023-09-30: $1.5M2023-12-31: $1.9M2024-03-31: $3.6M2025-03-31: $3.6M2025-06-30: $3.3M2025-09-30: $4.6M2026-03-31: $8.0M2026-06-30: $10.7M
    the quarter ended 30 Jun 20267 earlier quartersnormal: $3.6M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  6. 14 May 2026Financials change

    spent $8.0M on capital projects in the quarter ended 31 Mar 2026, 2.2× the same quarter last year.

    Same quarter last year: $3.6M; its normal quarter is $3.6M.

    See the evidence
    This period
    $8.0M (the quarter ended 31 Mar 2026)
    Normal quarter (median of 8 earlier)
    $3.6M
    Typical spread (median absolute deviation)
    $661K
    How far from its usual level
    +4.4
    Same quarter last year
    $3.6M
    History used
    3,652 days
    2024-03-31: $3.6M2024-06-30: $2.5M2024-09-30: $3.6M2024-12-31: $1.4M2025-03-31: $3.6M2025-06-30: $3.3M2025-09-30: $4.6M2025-12-31: $27.5M2026-03-31: $8.0M
    the quarter ended 31 Mar 20268 earlier quartersnormal: $3.6M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  7. 19 Feb 2026Financials change

    spent $27.5M on capital projects in the quarter ended 31 Dec 2025, 19× the same quarter last year.

    Same quarter last year: $1.4M; its normal quarter is $3.4M.

    See the evidence
    This period
    $27.5M (the quarter ended 31 Dec 2025)
    Normal quarter (median of 8 earlier)
    $3.4M
    Typical spread (median absolute deviation)
    $563K
    How far from its usual level
    +24.1
    Same quarter last year
    $1.4M
    History used
    3,562 days
    2023-12-31: $1.9M2024-03-31: $3.6M2024-06-30: $2.5M2024-09-30: $3.6M2024-12-31: $1.4M2025-03-31: $3.6M2025-06-30: $3.3M2025-09-30: $4.6M2025-12-31: $27.5M
    the quarter ended 31 Dec 20258 earlier quartersnormal: $3.4M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  8. 11 Aug 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  9. 11 Aug 2025Filings record

    Director or officer change

  10. 6 Mar 2025Insiders record

    SEMEDO ANTHONY B. (director) bought 2,100 shares of AORT ($53,145) (dated 5 Mar 2025)

  11. 6 Dec 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  12. 6 Dec 2023Filings record

    Director or officer change

  13. 29 Sep 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  14. 29 Sep 2022Filings record

    Director or officer change

  15. 2 Dec 2021Insiders record

    Davis John E (Senior VP, Global Sales) bought 600 shares of CRY ($10,398) (dated 1 Dec 2021)

  16. 1 Dec 2021Insiders record

    SEMEDO ANTHONY B. (director) bought 15,000 shares of CRY ($260,400) (dated 30 Nov 2021)

  17. 22 Sep 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  18. 22 Sep 2021Filings record

    Director or officer change

  19. 3 Aug 2021Financials change

    spent $5.7M on capital projects in the quarter ended 30 Jun 2021, 4.6× the same quarter last year.

    Same quarter last year: $1.2M; its normal quarter is $2.0M.

    See the evidence
    This period
    $5.7M (the quarter ended 30 Jun 2021)
    Normal quarter (median of 8 earlier)
    $2.0M
    Typical spread (median absolute deviation)
    $518K
    How far from its usual level
    +3.7
    Same quarter last year
    $1.2M
    History used
    3,926 days
    2019-06-30: $2.1M2019-09-30: $1.9M2019-12-31: $2.9M2020-03-31: $2.5M2020-06-30: $1.2M2020-09-30: $1.4M2020-12-31: $2.2M2021-03-31: $1.5M2021-06-30: $5.7M
    the quarter ended 30 Jun 20218 earlier quartersnormal: $2.0M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  20. 29 Mar 2021Filings record

    Director or officer change

  21. 23 Mar 2021Filings record

    Director or officer change

  22. 8 Mar 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  23. 8 Mar 2021Filings record

    Director or officer change

  24. 2 Oct 2020Insiders record

    Mackin James P (President & CEO) bought 7,500 shares of CRY ($125,550) [amended] (dated 1 Oct 2020)

  25. 18 Sep 2020Insiders record

    Davis John E (Senior VP, Global Sales) bought 10,000 shares of CRY ($166,500) (dated 17 Sep 2020)

  26. 18 Sep 2020Insiders record

    Bullock James (director) bought 10,000 shares of CRY ($166,300) (dated 17 Sep 2020)

  27. 14 Sep 2020Filings record

    Private placement of securities (Form D)

  28. 30 Apr 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  29. 30 Apr 2020Filings record

    Director or officer change

  30. 14 Nov 2019Insiders record

    Mackin James P (President & CEO) bought 5,000 shares of CRY ($117,350) (dated 13 Nov 2019)

  31. 1 Apr 2019Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  32. 1 Apr 2019Filings record

    Director or officer change

  33. 1 Jan 2019Financials change

    reported revenue of $64.6M for the quarter ended 30 Sep 2018, 1.5× the same quarter last year.

    Same quarter last year: $44.0M; its normal quarter is $46.5M.

    See the evidence
    This period
    $64.6M (the quarter ended 30 Sep 2018)
    Normal quarter (median of 8 earlier)
    $46.5M
    Typical spread (median absolute deviation)
    $2.0M
    How far from its usual level
    +3.9
    Same quarter last year
    $44.0M
    History used
    3,105 days
    2016-09-30: $45.3M2016-12-31: $45.0M2017-03-31: $45.1M2017-06-30: $47.8M2017-09-30: $44.0M2017-12-31: $52.8M2018-03-31: $61.9M2018-06-30: $68.5M2018-09-30: $64.6M
    the quarter ended 30 Sep 20188 earlier quartersnormal: $46.5M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  34. 20 Jun 2018Filings record

    Director or officer change

  35. 14 Mar 2018Filings record

    Director or officer change

  36. 12 Feb 2018Filings record

    Director or officer change

  37. 31 Jan 2018Filings record

    Director or officer change

  38. 1 Dec 2017Filings record

    Completed an acquisition or asset sale

  39. 2 Oct 2017Filings record

    Director or officer change

  40. 23 Mar 2017Filings record

    Director or officer change

Showing the newest 40 of 50 entries; narrow the window or the kind of data to see older ones.

Not listed: 397 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000784199
Ticker
AORT
Domain
artivion.com
Hq location
GA|KENNESAW|30144 (1 unverified)
Name
Artivion Chile SpA, Artivion Colombia SAS, Artivion Cyprus Limited, Artivion EMEA GmbH and 35 more
Uei
L23KYFC21D68
Wikidata
Q5190505
Wikipedia
Artivion
  • SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)151 records25 Jan 2016 to 6 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1200 data points31 Dec 2008 to 30 Oct 2026
  • SEC Form 4 insider transactions280 records, 540 data points19 Feb 2016 to 11 Sep 2026
  • FINRA short interest (twice monthly)345 data points31 Jan 2022 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)2426 data points24 Jan 2022 to 20 Nov 2026
  • USASpending.gov federal awards5917 data points2 Oct 2007 to 17 Nov 2026
  • Wikipedia pageviews1768 data points19 Jan 2022 to 21 Nov 2026